Additionally, several investigations and tests were not performed, which could have strengthened the diagnosis of NMS, such as dopamine agonist challenge, confirmatory muscle biopsy, serum iron, and urine myoglobin. The gene discussed is MB; the disease is neuroleptic malignant syndrome.